Bridgeway Capital Management’s IN8bio INAB Stock Holding History

Bridgeway Capital Management’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,443	Closed	-$87.4K	–	1288
2024 Q2	$87.4K	Hold	3,443	–	–	﹤0.01%	1170
2024 Q1	$122K	Buy	3,443 +833	+32%	+$31.4K	﹤0.01%	1183
2023 Q4	$108K	Hold	2,610	–	–	﹤0.01%	1228
2023 Q3	$81.4K	Buy	2,610 +977	+60%	+$36.6K	﹤0.01%	1255
2023 Q2	$75.5K	Sell	1,633 -834	-34%	-$52.2K	﹤0.01%	1294
2023 Q1	$96.2K	Hold	2,467	–	–	﹤0.01%	1246
2022 Q4	$171K	Hold	2,467	–	–	﹤0.01%	1121
2022 Q3	$149K	Buy	2,467 +467	+23%	+$31.4K	﹤0.01%	1200
2022 Q2	$146K	Hold	2,000	–	–	﹤0.01%	1155
2022 Q1	$208K	Buy	+2,000	New	+$224K	﹤0.01%	1166

Other funds holding INAB

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Bridgeway Capital Management's INAB Position: Q3 2024 in Review

Bridgeway Capital Management sold out of IN8bio (INAB) in Q3 2024, closing a stake of 3,443 shares — an estimated $87.4K sold.

Bridgeway Capital Management first reported a position in INAB in Q1 2022 and held it in 10 quarters. The position peaked at $208K in Q1 2022. 26 funds tracked by Wall St. Rank hold INAB as of Q3 2024.

Bridgeway Capital Management reported no remaining IN8bio position as of Q3 2024 after selling out during the quarter.
Bridgeway Capital Management sold 3,443 IN8bio shares in Q3 2024, an estimated $87.4K.
Bridgeway Capital Management first reported a position in IN8bio in Q1 2022 and held it in 10 quarters.
Bridgeway Capital Management's IN8bio position peaked at $208K in Q1 2022.
26 funds tracked by Wall St. Rank held IN8bio as of Q3 2024.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.